Therapeutic agent for cancer

Therapeutic agent for cancer

This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retino...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yuya Yoshida, Masanobu Takahashi, Chikashi Ishioka, Sakura Taniguchi
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Yuya Yoshida
Masanobu Takahashi
Chikashi Ishioka
Sakura Taniguchi
description This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retinoid compound or a derivative thereof. The compound that acts on a retinoid receptor may be ATRA, tamibarotene, or bexarotene. The BRAF inhibitor may be dabrafenib or encorafenib. The therapeutic agent for cancer may further contain an MEK inhibitor. The therapeutic agent for cancer may further contain a compound that acts on an EFG or EGF receptor.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB2629956A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB2629956A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB2629956A3</originalsourceid><addsrcrecordid>eNrjZJAJyUgtSixILS3JTFZITE_NK1FIyy9SSE7MS04t4mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8e5ORmZGlpamZo7GhFUAABB0It0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Therapeutic agent for cancer</title><source>esp@cenet</source><creator>Yuya Yoshida ; Masanobu Takahashi ; Chikashi Ishioka ; Sakura Taniguchi</creator><creatorcontrib>Yuya Yoshida ; Masanobu Takahashi ; Chikashi Ishioka ; Sakura Taniguchi</creatorcontrib><description>This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retinoid compound or a derivative thereof. The compound that acts on a retinoid receptor may be ATRA, tamibarotene, or bexarotene. The BRAF inhibitor may be dabrafenib or encorafenib. The therapeutic agent for cancer may further contain an MEK inhibitor. The therapeutic agent for cancer may further contain a compound that acts on an EFG or EGF receptor.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241113&amp;DB=EPODOC&amp;CC=GB&amp;NR=2629956A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241113&amp;DB=EPODOC&amp;CC=GB&amp;NR=2629956A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Yuya Yoshida</creatorcontrib><creatorcontrib>Masanobu Takahashi</creatorcontrib><creatorcontrib>Chikashi Ishioka</creatorcontrib><creatorcontrib>Sakura Taniguchi</creatorcontrib><title>Therapeutic agent for cancer</title><description>This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retinoid compound or a derivative thereof. The compound that acts on a retinoid receptor may be ATRA, tamibarotene, or bexarotene. The BRAF inhibitor may be dabrafenib or encorafenib. The therapeutic agent for cancer may further contain an MEK inhibitor. The therapeutic agent for cancer may further contain a compound that acts on an EFG or EGF receptor.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJyUgtSixILS3JTFZITE_NK1FIyy9SSE7MS04t4mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8e5ORmZGlpamZo7GhFUAABB0It0</recordid><startdate>20241113</startdate><enddate>20241113</enddate><creator>Yuya Yoshida</creator><creator>Masanobu Takahashi</creator><creator>Chikashi Ishioka</creator><creator>Sakura Taniguchi</creator><scope>EVB</scope></search><sort><creationdate>20241113</creationdate><title>Therapeutic agent for cancer</title><author>Yuya Yoshida ; Masanobu Takahashi ; Chikashi Ishioka ; Sakura Taniguchi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB2629956A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Yuya Yoshida</creatorcontrib><creatorcontrib>Masanobu Takahashi</creatorcontrib><creatorcontrib>Chikashi Ishioka</creatorcontrib><creatorcontrib>Sakura Taniguchi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Yuya Yoshida</au><au>Masanobu Takahashi</au><au>Chikashi Ishioka</au><au>Sakura Taniguchi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Therapeutic agent for cancer</title><date>2024-11-13</date><risdate>2024</risdate><abstract>This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retinoid compound or a derivative thereof. The compound that acts on a retinoid receptor may be ATRA, tamibarotene, or bexarotene. The BRAF inhibitor may be dabrafenib or encorafenib. The therapeutic agent for cancer may further contain an MEK inhibitor. The therapeutic agent for cancer may further contain a compound that acts on an EFG or EGF receptor.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB2629956A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Therapeutic agent for cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A36%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Yuya%20Yoshida&rft.date=2024-11-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB2629956A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true